Literature DB >> 18003569

Probability of Interference between LP-LDC and LBT MICS implants in a medical care facility.

Brian Sutton1, Paul Stadnik, James Nelson, Larry Stotts.   

Abstract

The latest generation of medical implants incorporate RF telemetry to facilitate communication of patient data to the patient's physician. Regulatory agencies have enabled medical implant telemetry by allocating RF spectrum in the 402-405 MHz band. The first generation of regulations mandated the use of a Listen-Before-Talk (LBT) protocol. Most of these regulators, recognizing the need for expanded services, are modifying the regulations to allow a Low-Power Low-Duty-Cycle (LP-LDC) protocol as an alternative access method. Medical implant device manufacturers incorporate mitigation techniques to maintain communication in the face of expected link impairments. Designers must understand the expected operational environment and probability of interference in order to incorporate appropriate levels of such mitigation techniques. In this study the authors use the SEAMCAT-3 modeling tool to examine the probability of interference between LP-LDC and LBT medical implants in a medical care facility, where a high density of implants using either protocol can be expected. This study shows that because LP-LDC transmitters operate with very low power and low duty cycle, they can safely coexist with LBT devices, with extremely low probability of interference. Furthermore, with appropriate mitigation techniques, the probability of any harmful interference is virtually non-existent.

Entities:  

Mesh:

Year:  2007        PMID: 18003569     DOI: 10.1109/IEMBS.2007.4353903

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  1 in total

1.  "Pseudo" Faraday cage: a solution for telemetry link interaction between a left ventricular assist device and an implantable cardioverter defibrillator.

Authors:  Sony Jacob; Prasad K Cherian; Waqas S Ghumman; Mithilesh K Das
Journal:  J Interv Card Electrophysiol       Date:  2009-07-28       Impact factor: 1.900

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.